The effectiveness of vaccines against the new variant remains unknown, although animal data shows promising results.
A cluster of mpox cases in the Democratic Republic of the Congo sparks worries of a wider outbreak. A virulent strain of the ...
The Government Accountability Office (GAO) says in a new report that the Department of Health and Human Services’s (HHS) ...
Mpox is caused by a virus in the same family as smallpox. Its symptoms include swollen lymph nodes, muscle aches, and fever, ...
A regulatory decision is expected on February 14, 2025. The Food and Drug Administration has accepted for review the Biologics License Application for GSK’s 5-in-1 meningococcal ABCWY (MenABCWY) ...
The U.S. Food and Drug Administration has accepted for review a Biologics License Application or BLA for GSK plc.'s (GSK, GSK.L) ...
The vaccine combines the antigenic components of its two meningococcal vaccines: Bexsero and Menveo. The action date is Feb. 14, 2025.
Australia’s vaccine regulator, the Australian Technical Advisory Group on Immunisation (ATAGI), is still determinedly ...
Indian generic drug major Dr Reddy's Laboratories saw its shares dip 1.2% to 4,411 rupees, as it revealed it has entered into a definitive agreement to acquire the US generic prescription product ...
Oriol Mitja had an upbringing that suggested he could be a doctor: his late grandfather was the founder and first chancellor of Barcelona's Autonomous University, and both his parents are doctors. But ...